Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor

Jee Woong Park; Sreenivasa Saravan Kallempudi; Javed H. Niazi; Yasar Gurbuz; Byung Soo Youn; Man Bock Gu

doi:10.1016/j.bios.2012.05.036

Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor

Jee Woong Park, Sreenivasa Saravan Kallempudi, Javed H. Niazi, Yasar Gurbuz, Byung Soo Youn, Man Bock Gu^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Abstract

A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (K_d=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (K_d=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.

Original language	English
Pages (from-to)	233-238
Number of pages	6
Journal	Biosensors and Bioelectronics
Volume	38
Issue number	1
DOIs	https://doi.org/10.1016/j.bios.2012.05.036
Publication status	Published - 2012 Oct

Bibliographical note

Funding Information:
This work was supported by a grant from the Ministry for Health, Welfare and Family Affairs, Republic of Korea (Grant no. A081023 ), the National Research Foundation (NRF) of Korea grant funded by the Korea government (Ministry of Education, Science and Technology [MEST] , Grant no. 2010-00579-KORANET ), and the Scientific and Technological Research Council of Turkey (TUBITAK) , Project no. 110E287 .

Keywords

Aptamer
Capacitive biosensor
Nampt (PBEF/visfatin)
SELEX

ASJC Scopus subject areas

Biotechnology
Biophysics
Biomedical Engineering
Electrochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.bios.2012.05.036

Cite this

@article{a517878ecb0e4e11b3fb9ab8706e5cad,

title = "Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor",

abstract = "A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (Kd=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (Kd=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.",

keywords = "Aptamer, Capacitive biosensor, Nampt (PBEF/visfatin), SELEX",

author = "Park, \{Jee Woong\} and \{Saravan Kallempudi\}, Sreenivasa and Niazi, \{Javed H.\} and Yasar Gurbuz and Youn, \{Byung Soo\} and Gu, \{Man Bock\}",

note = "Funding Information: This work was supported by a grant from the Ministry for Health, Welfare and Family Affairs, Republic of Korea (Grant no. A081023 ), the National Research Foundation (NRF) of Korea grant funded by the Korea government (Ministry of Education, Science and Technology [MEST] , Grant no. 2010-00579-KORANET ), and the Scientific and Technological Research Council of Turkey (TUBITAK) , Project no. 110E287 . ",

year = "2012",

month = oct,

doi = "10.1016/j.bios.2012.05.036",

language = "English",

volume = "38",

pages = "233--238",

journal = "Biosensors and Bioelectronics",

issn = "0956-5663",

publisher = "Elsevier Ltd",

number = "1",

}

TY - JOUR

T1 - Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor

AU - Park, Jee Woong

AU - Saravan Kallempudi, Sreenivasa

AU - Niazi, Javed H.

AU - Gurbuz, Yasar

AU - Youn, Byung Soo

AU - Gu, Man Bock

N1 - Funding Information: This work was supported by a grant from the Ministry for Health, Welfare and Family Affairs, Republic of Korea (Grant no. A081023 ), the National Research Foundation (NRF) of Korea grant funded by the Korea government (Ministry of Education, Science and Technology [MEST] , Grant no. 2010-00579-KORANET ), and the Scientific and Technological Research Council of Turkey (TUBITAK) , Project no. 110E287 .

PY - 2012/10

Y1 - 2012/10

N2 - A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (Kd=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (Kd=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.

AB - A single-stranded DNA (ssDNA) aptamer was successfully developed to specifically bind to nicotinamide phosphoribosyl transferase (Nampt) through systematic evolution of ligands by exponential enrichment (SELEX) and successfully implemented in a gold-interdigitated (GID) capacitor-based biosensor. Surface plasmon resonance (SPR) analysis of the aptamer revealed high specificity and affinity (Kd=72.52nM). Changes in surface capacitance/charge distribution or dielectric properties in the response of the GID capacitor surface covalently coupled to the aptamers in response to changes in applied AC frequency were measured as a sensing signal based on a specific interaction between the aptamers and Nampt. The limit of detection for Nampt was 1ng/ml with a dynamic serum detection range of up to 50ng/ml; this range includes the clinical requirement for both normal Nampt level, which is 15.8ng/ml, and Nampt level in type 2 diabetes mellitus (T2DM) patients, which is 31.9ng/ml. Additionally, the binding kinetics of aptamer-Nampt interactions on the capacitor surface showed that strong binding occurred with increasing frequency (range, 700MHz-1GHz) and that the dissociation constant of the aptamer under the applied frequency was improved 120-240 times (Kd=0.3-0.6nM) independent on frequency. This assay system is an alternative approach for clinical detection of Nampt with improved specificity and affinity.

KW - Aptamer

KW - Capacitive biosensor

KW - Nampt (PBEF/visfatin)

KW - SELEX

UR - https://www.scopus.com/pages/publications/84864393537

U2 - 10.1016/j.bios.2012.05.036

DO - 10.1016/j.bios.2012.05.036

M3 - Article

C2 - 22704839

AN - SCOPUS:84864393537

SN - 0956-5663

VL - 38

SP - 233

EP - 238

JO - Biosensors and Bioelectronics

JF - Biosensors and Bioelectronics

IS - 1

ER -

Rapid and sensitive detection of Nampt (PBEF/visfatin) in human serum using an ssDNA aptamer-based capacitive biosensor

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this